Clinical Maestro™ by Strategikon Pharma is the only commercially available software platform for clinical trial business management.
Strategikon Pharma has raised $2.3M in total funding. The most recent round was Debt Financing. The last funding was announced in June 2025.
Strategikon Pharma's investors include Alumni Ventures, Wing Venture Capital, Osage Venture Partners, Golden Seeds, Decathlon Capital Partners.
Strategikon Pharma is headquartered in San Rafael, United States.
Clinical Maestro™ by Strategikon Pharma is the only commercially available software platform for clinical trial business management.
Strategikon Pharma is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Strategikon Pharma — Funding & Investors." VCBacked, June 10, 2025, https://www.vcbacked.co/company/strategikon-pharma. Accessed November 13, 2026.
VCBacked. (2025). Strategikon Pharma — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/strategikon-pharma
{{cite web |title=Strategikon Pharma — Funding & Investors |url=https://www.vcbacked.co/company/strategikon-pharma |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Strategikon Pharma? Request a listing update